HRS Aluglaze Board of Directors

Get the latest insights into the leadership at HRS Aluglaze. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rupesh Pravinbhai Shah Chairman & Managing Director
Ms. Pinky Rupesh Shah Executive Director
Mr. Hrishikesh Rupesh Shah Executive Director
Mr. Shail Jayesh Shah Ind. Non-Executive Director
Ms. Heta Hiren Shah Ind. Non-Executive Director
Mr. Niki Nitin Thakkar Ind. Non-Executive Director

HRS Aluglaze Share price

HRS

162.05

0.05 (0.03%)
Last updated on 8 Jan, 2026 | 15:29 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

163.60

Today's Low

162.05

52 Week Low

126.00

52 Week High

170.00

alert_iconThe current prices are delayed, login to your account for live prices

HRS Aluglaze FAQs

The board at HRS Aluglaze consists of experienced professionals, including Mr. Rupesh Pravinbhai Shah , Ms. Pinky Rupesh Shah , and others, overseeing the company’s strategic and corporate governance.

Directors at HRS Aluglaze are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rupesh Pravinbhai Shah is the current chairman at HRS Aluglaze.

Executive directors at HRS Aluglaze are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, HRS Aluglaze adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At HRS Aluglaze, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.